title: Consumption of C4b-binding protein (C4BP) during in vivo activation of the classical complement pathway.
abstract: C4BP has a central role in regulating the classical complement (C') pathway, but it is still uncertain whether or not it is consumed during in vivo complement activation. Attempts to demonstrate changes in C4BP plasma levels in systemic lupus erythematosus and essential mixed cryoglobulinaemia have failed, probably due to up-regulation of this protein during the inflammatory reaction. We have studied one patient with severe post-transfusion complement-mediated anaphylaxis (CMA), and 67 patients with hereditary C1 inhibitor deficiency (hereditary angioedema (HAE)). The first of these two conditions is characterized by the absence of systemic inflammatory reaction and the second by acute and chronic activation of the C' classical pathway. C4BP, C4BP-C4b complex, and soluble terminal C' complex (sC5b-9) were measured in the patients' plasmas by ELISA techniques and C3a and C4a by radioimmunoassays. In CMA, 15 min after the transfusion, there was a massive C' activation, with increases in C4a, C3a, sC5b-9, C4BP-C4b complexes and decreases in C4, C3 and C4BP. All parameters reverted to preinfusion values within 24 h. Depletion of C4 was correlated with that of C4BP. In patients with HAE, the median value of C4BP (83% range 54-165) was significantly lower (P < 0.0001) than in normal controls (99% range 70-159), with no difference between patients in remission or during acute attacks. C4BP-C4b complexes could not be detected in HAE patients. The results of this study indicate that C4BP is consumed in vivo during acute, and possibly during chronic activation of the C' classical pathway, and that this protein, after interaction with C4b, not longer circulates in plasma.
authors.affiliation: Department of Internal Medicine, Maggiore Hospital IRCCS, University of Milan, Milan, Italy. Luigi.Bergamaschini@unimi.it
authors.forename: L
authors.initials: L
authors.lastname: Bergamaschini
authors.forename: A
authors.initials: A
authors.lastname: Miedico
authors.forename: M
authors.initials: M
authors.lastname: Cicardi
authors.forename: R
authors.initials: R
authors.lastname: Coppola
authors.forename: E N
authors.initials: EN
authors.lastname: Faioni
authors.forename: A
authors.initials: A
authors.lastname: Agostoni
mesh_terms: D000328:Adult; D003174:Complement C1 Inactivator Proteins / Q000172:deficiency; D015935:Complement C4b / Q000378:metabolism; D003169:Complement Inactivator Proteins; D003171:Complement Pathway, Classical; D005260:Female; D006023:Glycoproteins; D006801:Humans; D011951:Receptors, Complement / Q000378:metabolism*
chemical_list: D003174:Complement C1 Inactivator Proteins; D003169:Complement Inactivator Proteins; D006023:Glycoproteins; D011951:Receptors, Complement; D015935:Complement C4b